Dr. Hanzy F. Bustamante, MD

Dr. Bustamante practices at St. Mark's Hospital in Salt Lake City, Utah, part of HCA Healthcare.

Dr. Bustamante's NPI, 1508828641, was assigned on April 4, 2006. Dr. Bustamante graduated from University of Santo Tomas in 1998. Dr. Bustamante's Texas license number on file is M1551.

Dr. Bustamante's primary practice is St. Mark's Hospital, at 1200 East 3900 South, Salt Lake City, UT 84124 in Salt Lake County. The practice phone is (801) 268-7111.

Dr. Bustamante's primary practice is St. Mark's Hospital in Salt Lake City, Utah, part of HCA Healthcare. Dr. Bustamante is also affiliated with Baptist Medical Center. The medical group on file is Sound Physicians. Dmand AI also links Dr. Bustamante to 4 more hospitals, 10 medical groups, 5 skilled nursing facilities and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bustamante practices, 12 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Bustamante's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Bustamante is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Bustamante's licenses on file in 5 states: Texas, North Carolina, Nevada, Utah and Illinois.

Dmand AI lists acid reflux, acute diabetes, acute respiratory failure, aneurysm, arthritis, atrial fibrillation and flutter, cerebrovascular disease and chronic diabetes among the conditions Dr. Bustamante treats.

CMS data shows 420 Medicare services from Dr. Bustamante across 4 procedure codes in 2024, for 137 Medicare patients. Medicare paid $33,062 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 137 Medicare patients who saw Dr. Bustamante in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bustamante's median patient age at 76, with 53% women.

In 2024, Dr. Bustamante wrote 2,752 Medicare Part D claims for 297 patients. 88% of them were for generic drugs. CMS names the drug for 2,131 of them, across 62 drugs with 11 or more claims each, at $161,411 in total drug cost. In 2023, CMS named 145 claims across 9 drugs.

Dr. Bustamante accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 10 general payments to Dr. Bustamante from 6 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Neurocrine BioSciences, Inc. paid the most, $125.

Dr. Bustamante graduated from University of Santo Tomas in 1998.

Dr. Bustamante is in network with 22 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.